Results 211 to 220 of about 1,773,184 (307)

Comparison between muscle strength and flexibility of the lower limbs of individuals with and without Diabetes Mellitus type 2

, 2017
Suzane Stella Bavaresco
openalex   +1 more source

Suprainguinal Lateral Femoral Cutaneous Neurectomy for Recurrent Meralgia Paresthetica: A Technique Guide

Arthroscopy Techniques, EarlyView.
Abstract Meralgia paresthetica (MP) is a neuropathy caused by injury or compression of the lateral femoral cutaneous nerve (LFCN), presenting as numbness, tingling, or burning pain in the lateral thigh. While surgical decompression has traditionally been a common surgical treatment for MP, recently, fully transecting the LFCN is increasingly becoming ...
Joshua T. Finerty, Allison R. Garden, Manuel A. Romero‐Padron, Joshua S. Everhart   +3 more
wiley   +1 more source

K svedeniyu avtorov

Сахарный диабет, 2013
Editorial team Diabetes Mellitus
doaj  

Maternal serum NRF2 at 12 weeks as a biomarker for development of gestation diabetes mellitus. [PDF]

Arch Gynecol Obstet
Ge J, Jia X, Tang W, Lu D, Wang L.
europepmc   +1 more source

A chromosome study in a case of Klinefelter's syndrome associated with diabetes mellitus and polycythemia vera.

, 1982
Eiji HOSHINO, Noriko Nakada, K Ishitobi, Masaki Yamashita, Yoshimichi HARADA   +4 more
openalex   +2 more sources

Prescribing competence: The pros and cons of different methods for assessment

British Journal of Clinical Pharmacology, EarlyView.
Evaluating a medical graduate’s competence in rational prescribing is challenging. With the aim to guide and inspire teachers, this narrative review explores different methods that can be used to assess prescribing competence. Each method has its own advantages and disadvantages, and thus a mix of different assessment methods is needed throughout the ...
David J. Brinkman, Erik M. Donker, Jelle Tichelaar, on behalf of the CP4T programme   +3 more
wiley   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Lower extremity osseointegration for amputees with diabetes mellitus and vascular disease. [PDF]

OTA Int
Hoellwarth JS, Yu LC, DeSena TD, Wongcharoenwatana J, Reif TJ, Rozbruch SR.   +5 more
europepmc   +1 more source

Diabetes mellitus : an advance on diagnosis and medical treatment.3.Recent topics surrounding diabetes mellitus.1.Gene of insulin and its abnormality.

, 1991
小林 正
openalex   +2 more sources

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source